A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE

Cancer Genetics Education Program

Cancer Genetics Education Program
The Division of Clinical Cancer Genetics at City of Hope offers educational coursesand self-teaching tools forprofessionals in the fields of cancer and cancer genetics.ThisCancer Genetics Education Program (CGEP) is supported inpart by funding fromthe NCI (IRC4CA153828-01 andIR25CA112486).
 
Dramatic advances in our understanding of the genetic basis for cancer have led to the development of new technologies and tools for genetic cancer risk assessment. The Cancer Genetics Education Program at City of Hope offers a series of comprehensive learning tools designed to enhance the education of primary care physicians and clinical oncology professionals on the topics of cancer genetics and cancer risk assessment, and their application to patient care. Through a series of educational courses, workshops, seminars, newsletters and a direct, interactive electronic communications network, professionals can be tutored in the latest information on cancer molecular genetics, the fundamentals of obtaining an adequate family history, understanding genetic cancer risk assessment, ethical and legal complexities of genetic testing, and other current/timely topics.
 
Cancer Genetics Career Development Program
City of Hope offers an innovative  Cancer Genetics Career Development Program (CGCDP) whichprovides interdisciplinary training focused on cancer genetics and cancer prevention control research. The Traineeship is open to three applicants per year.
 
Intensive Course in Cancer Risk Assessment
City of Hope's Division of Clinical Cancer Genetics offers an annual CME/CEU-accredited multi-modal intensive course to address the need for professional training in clinical cancer genetics and research collaboration for community-based clinicians.
 
Clinical Cancer Genetics Community of Practice
City of Hope CCG Community of Practice brings cancer genetics practitioners from diverse practice settings together for professional learning, enduring patient-centered support and dynamic community-based research collaborations to promote quality care and improved patient outcomes across the U.S. and internationally.

Working Group

Clinical Cancer Genetics (CCG) Working Group is a CME-accredited interdisciplinary cancer genetics case conference series conducted each week by the City of Hope clinical team. CSPPN and affiliated clinicians across the U.S. present cases from their community practices via web conferencing for discussion and recommendations on risk assessment, surveillance, risk management and identification of research eligibility for cases covering the full spectrum of hereditary cancer.

Cancer Genetics Community Link

The Cancer Genetics Community Discussion Board is a Web-based discussion board for collaborative, interdisciplinary practice-based support and continuing professional learning. CCG Community of Practice members are encouraged to post and respond to case-based questions and share resources with a growing, multidisciplinary network of professionals engaged in the practice of clinical cancer genetics. Messages are posted and archived under topic-specific forums, allowing members to search for information by topic of interest.
 
Case Consultation Questions

Breast/Ovarian Cancers (Uninformative BRCA Test Results)

Breast/Ovarian Cancers (Testing)

Breast/Ovarian Cancers (Probability/Empiric Risks)

Breast/Ovarian Cancers (Risk Management)

Breast/Ovarian Cancers (Hormone Replacement Therapy)

Male Breast Cancers

Gastrointestinal Cancers (Lynch Related)

Gastrointestinal Cancers (Polyposis Syndromes)

Gastrointestinal Cancers (Non-Colorectal)

Gastrointestinal Cancers (Risk Management)

Genitourinary Cancer

Genodermatoses

Endocrine Neoplasias

Pediatric Cancers

ELSI-Ethical, Legal, Social Issues

 

Clinical Resources

Progeny/Pedigree Drawing Issues

 

Clinical Cancer Genetics Working Group

CCG Working Group Case Conferences

 

Comments/Suggestions

Suggestion/Comment Box

 

Clinical Cancer Genetics Events Calendar

Clinical Cancer Genetics
The City of Hope Division of Clinical Cancer Genetics is committed to being a national leader in the advancement of cancer genetics, screening and prevention, through innovative patient care, research and education.

Contact Us
  • 800-826-HOPE (4673)
  • For more information about the Cancer Screening & Prevention Program, call 626-256-8662, ext. 2.
CCG Newsletter: Closing the Loop
View the current issue: CCG 2013 Newsletter 7-14-14
Beckman Research Institute of City of Hope is internationally  recognized for its innovative biomedical research.
City of Hope is one of only 41 Comprehensive Cancer Centers in the country, the highest designation awarded by the National Cancer Institute to institutions that lead the way in cancer research, treatment, prevention and professional education.
Learn more about City of Hope's institutional distinctions, breakthrough innovations and collaborations.
NEWS & UPDATES
  • Undergoing reconstructive surgery may seem like a forgone conclusion for survivors of breast cancer, but that doesn’t appear to be the case. A new study has found that most breast cancer survivors who undergo a mastectomy decide against surgical reconstruction of their breasts. The reasons for such a deci...
  • Nearly four decades ago, City of Hope began its bone marrow transplant program. Its first transplant reunion celebration was a single patient and his donor, also his brother. This year, City of Hope welcomed hundreds of hematopoietic cell transplant (HCT) recipients to the annual bone marrow transplant/HCT reun...
  • The burgeoning type 2 diabetes epidemic casts a pall over the health of America’s public. New research now shows the looming threat is getting worse. Much worse. A diabetes trends study published earlier this month in the Lancet Diabetes and Endocrinology by researchers at the federal Centers for Disease Contro...
  • An aspirin a day might help keep breast cancer away for some breast cancer survivors, a new study suggests. Obese women who have had breast cancer could cut their risk of a recurrence in half if they regularly take aspirin or other nonsteroidal anti-inflammatory drugs, called NSAIDs, report researchers from the...
  • Christine Crews isn’t only a fitness enthusiast, she’s also a personal trainer and fitness instructor. Being active defines her life. So when she was diagnosed with bladder cancer at age 30, she decided she absolutely couldn’t let the disease interfere with that lifestyle. And it didn’t. For t...
  • Cancer treatment and the cancer itself can cause changes in your sense of taste or smell. These side effects typically subside after treatment ends, but there are ways to help alleviate those bitter and metallic tastes in your mouth. Here are tips from the National Cancer Institute to help keeps tastes and food...
  • Immunotherapy — using one’s immune system to treat a disease — has been long lauded as the “magic bullet” of cancer treatments, one that can be more effective than the conventional therapies of surgery, radiation or chemotherapy. One specific type of immunotherapy, called adoptive T cell thera...
  • Today, when cancer spreads from its original site to other parts of the body, a process known as metastasis, patients face an uphill battle. Treatments are poorly effective, and cures are nearly impossible. Further, incidence rates for these types of cancers are increasing – particularly for cancers that have s...
  • Thanks to the California Institute for Regenerative Medicine (CIRM), high school students across the state gained valuable hands-on experience with stem cell research this summer. City of Hope hosted eight of those students. As part of the CIRM Creativity Awards program, the young scholars worked full time as m...
  • Radiation therapy can help cure many children facing Hodgkin lymphoma and other cancers. When the radiation is delivered to a girl’s chest, however, it can lead to a marked increase in breast cancer risk later in life. A recent multi-institutional study that included City of Hope’s Smita Bhatia, M.D., M.P.H., t...
  • A patient diagnosed with cancer – especially a rare, advanced or hard-to-treat cancer – needs specialized care from exceptionally skilled and highly trained experts. That kind of care saves lives, improves quality of life and keeps families whole. That kind of care is best found at comprehensive cancer centers ...
  • Appetite loss may be common during cancer treatment, lasting throughout your therapy or only occasionally, but it can be managed. Below are tips from the National Cancer Institute (NCI) that can help you keep your weight up and, in doing so, keep your body well-nourished. (See the end of this article for a deli...
  • Myelodysplasia, sometimes referred to as myelodysplastic syndrome or MDS, is a rare group of blood disorders caused by disrupted development of blood cells within the bone marrow, resulting in a decreased number of healthy blood cells. People diagnosed with the condition, considered a precancer, may be at great...
  • Twenty years ago, scientists discovered that a mutation in a gene now widely known as BRCA1 was linked to a sharply increased risk of breast cancer, paving the way for a new chapter in identifying women at risk of the disease and giving them options to potentially avoid an aggressive cancer. But experts have al...
  • The Eugene and Ruth Roberts Summer Student Academy at City of Hope turned 54 this year. Marking the occasion, the academy announced a new scholarship in honor of longtime director Paul Salvaterra, Ph.D. Salvaterra, a professor in City of Hope’s Department of Neurosciences, has led the summer student acade...